Hepion Pharmaceuticals, Inc. (HEPA) › Operating IncomeHepion Pharmaceuticals, Inc. (HEPA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2014: -$1.67M2015: -$13.96M2016: -$20.81M2017: -$20.65M2018: -$14.59M2019: -$7.77M2020: -$20.15M2021: -$30.40M2022: -$45.49M2023: -$48.45M2024: -$19.35M2025: -$4.16M-$4.16M2014Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$4.16M+78.5%2024-$19.35M+60.1%2023-$48.45M-6.5%2022-$45.49M-49.6%2021-$30.40M-50.9%2020-$20.15M-159.3%2019-$7.77M+46.8%2018-$14.59M+29.3%2017-$20.65M+0.8%2016-$20.81M-49.0%2015-$13.96M-734.9%2014-$1.67M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share